Last week, the Centers for Disease Control and Prevention (CDC) published an article in the Morbidity and Mortality Weekly Report (MMWR) titled “Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease — United States”
This article received a lot of attention in the media. However, not everyone was thrilled with the publication.
The Chief Executive Officer of LymeDisease.org, Lorraine Johnson, JD, MBA joined me to discuss the issues she has with the report–both scientific and ethical. In addition, Ms. Johnson discussed issues concerning chronic Lyme to include treatment and diagnosis–two issues that divide Lyme advocates and the CDC and the Infectious Diseases Society of America (IDSA).
She also discussed the big data project, MyLymeData.
- Lyme disease expert talks diagnosis, treatment and ‘chronic Lyme’
- Lyme Madness author, Lori Dennis, for the full show
- Lyme disease bacteria, Borrelia, able to form biofilms that make them resistant to treatment
- Lyme disease: Global Lyme Diagnostics announces new test is available
- Powassan could become a greater public health threat than Lyme disease: Yale researcher
- Lyme disease still has a big cost to society when it comes to outdoor activities: Yale researchers
- Post-Treatment Lyme Disease Syndrome: UND researchers seek treatment
- Lyme Disease Biobank launched, one-stop access to patient samples
- Babesiosis cases likely on the rise